These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8112197)

  • 1. Insulin-like growth factor I therapy for diabetes mellitus?
    Kolaczynski JW; Caro JF
    Diabetes Care; 1994 Jan; 17(1):92-6. PubMed ID: 8112197
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of rhIGF-I in diabetes and conditions of insulin resistance.
    Froesch ER; Hussain M
    J Intern Med; 1993 Dec; 234(6):561-70. PubMed ID: 8258747
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic and therapeutic effects of insulin-like growth factor I.
    Froesch ER; Zenobi PD; Hussain M
    Horm Res; 1994; 42(1-2):66-71. PubMed ID: 7959637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity.
    Hussain MA; Schmitz O; Christiansen JS; Zapf J; Froesch ER
    Metabolism; 1995 Oct; 44(10 Suppl 4):108-12. PubMed ID: 7476302
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks.
    Kolaczynski JW; Caro JF
    Ann Intern Med; 1994 Jan; 120(1):47-55. PubMed ID: 8250456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of insulin-like growth factor I with special reference to diabetes.
    Froesch ER; Hussain M
    Acta Paediatr Suppl; 1994 Apr; 399():165-70. PubMed ID: 7949607
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.
    Laron Z
    Drugs; 1993 Jan; 45(1):1-8. PubMed ID: 7680980
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of insulin-like growth factor I on alveolar bone remodeling in diabetic rats.
    Fang Y; Wang LP; Du FL; Liu WJ; Ren GL
    J Periodontal Res; 2013 Apr; 48(2):144-50. PubMed ID: 22834984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IGF system in metabolism regulation.
    Binoux M
    Diabete Metab; 1995 Dec; 21(5):330-7. PubMed ID: 8586149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Miller MS
    Am J Pathol; 1999 Nov; 155(5):1651-60. PubMed ID: 10550321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factor system and diabetes--an overview.
    Heald A; Stephens R; Gibson JM
    Diabet Med; 2006 Mar; 23 Suppl 1():19-24. PubMed ID: 16483261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemic effect of nicotinamide in diabetes mellitus].
    Obrosova IG; Efimov AS; Velikiĭ NN; Avramenko NL; Zubkova ST
    Farmakol Toksikol; 1987; 50(2):113-5. PubMed ID: 2953627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I: a treatment for type 2 diabetes revisited.
    Murphy LJ
    Endocrinology; 2006 Jun; 147(6):2616-8. PubMed ID: 16707730
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.
    Quin JD; Fisher BM; Paterson KR; Inoue A; Beastall GH; MacCuish AC
    N Engl J Med; 1990 Nov; 323(20):1425-6. PubMed ID: 2233914
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium-glucose transporter-2 inhibition as an antidiabetic therapy.
    Ferrannini E
    Nephrol Dial Transplant; 2010 Jul; 25(7):2041-3. PubMed ID: 20466683
    [No Abstract]   [Full Text] [Related]  

  • 17. Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats.
    Luo C; Yang H; Tang C; Yao G; Kong L; He H; Zhou Y
    Int Immunopharmacol; 2015 Sep; 28(1):744-50. PubMed ID: 26263168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human insulin-like growth factor I and treatment in diabetes].
    Koivisto VA
    Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin, IGF-I and growth in diabetic rats.
    Robinson IC; Clark RG; Carlsson LM
    Nature; 1987 Apr 9-15; 326(6113):549. PubMed ID: 3550476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relative insulin deficiency as a primary factor in pathogenesis of spontaneous diabetes mellitus].
    Baranov VG; Iaroshevskiĭ IuA
    Probl Endokrinol (Mosk); 1980; 26(2):3-8. PubMed ID: 6990401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.